Mastocytosis clinical trials

The registry lists 49 studies for Mastocytosis across more than 10 countries. 14 are recruiting or about to start. 22 of them are mainly about Mastocytosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 2 narrower conditions too, such as Leukemia, Mast-Cell: 132 studies, 26 open.

Get an email when these change. Save the Mastocytosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 25
Recruiting: 14
Status unknown: 6
Terminated: 2
Active, not recruiting: 1
Withdrawn: 1

Phase

Phase 2: 16
Phase 3: 6
Phase 4: 1
Phase 1: 1

Where

United States: 21
France: 12
Germany: 8
Netherlands: 5
Spain: 5
Poland: 4

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (8) · University Hospital, Toulouse (4) · Blueprint Medicines Corporation (4) · AB Science (4) · M.D. Anderson Cancer Center (2) · Hospital Virgen de la Salud (2) · University of Zurich (2) · Cogent Biosciences, Inc. (2)

What is being tested here

Drugs under test in Mastocytosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Masitinib	1	2	4
Bezuclastinib	1	0	2
Imatinib	0	0	3
Fludarabine	0	0	1
Busulfan	0	0	1
Cyclophosphamide	0	0	1
Tacrolimus	0	0	1
Mycophenolic Acid	0	0	1
Dasatinib	0	0	1
2019-nCoV Vaccine mRNA-1273	0	0	1

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open

Coming up

1phase 3 study under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Jul 2027Angioedema Biomarker Research Study · Foundation For Rare Disease Research
Oct 2027Myeloproliferative Neoplasms (MPNs) Patient Registry · University Health Network, Toronto

Who these studies take

Of the 14 Mastocytosis studies recruiting now, 11 (79%) set no upper age limit and 2 (14%) stop at 75 or younger. 6 (43%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (29%) take healthy volunteers.

Recruiting studies that take each age, of 14
Age	Women	Men
10	5 (36%)	5 (36%)
18	14 (100%)	14 (100%)
30	14 (100%)	14 (100%)
40	14 (100%)	14 (100%)
50	14 (100%)	14 (100%)
65	14 (100%)	14 (100%)
75	14 (100%)	14 (100%)
85	11 (79%)	11 (79%)

Across all 49 studies, recruiting or not: 31% stop at 75 or younger and 12% at 65; 45% take children; 2% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 49 of 49. search them.